Ryo Nagase

621 total citations
10 papers, 530 citations indexed

About

Ryo Nagase is a scholar working on Nephrology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Ryo Nagase has authored 10 papers receiving a total of 530 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Nephrology, 5 papers in Clinical Biochemistry and 2 papers in Molecular Biology. Recurrent topics in Ryo Nagase's work include Chronic Kidney Disease and Diabetes (6 papers), Advanced Glycation End Products research (5 papers) and Immune cells in cancer (2 papers). Ryo Nagase is often cited by papers focused on Chronic Kidney Disease and Diabetes (6 papers), Advanced Glycation End Products research (5 papers) and Immune cells in cancer (2 papers). Ryo Nagase collaborates with scholars based in Japan, United States and Ireland. Ryo Nagase's co-authors include Hirofumi Makino, Kenichi Shikata, Jun Wada, Hitomi Usui, Yasushi Shikata, Shinichi Okada, Yuichi Kido, Mitsuhiro Matsuda, Daisuke Ogawa and Daisuke Ogawa and has published in prestigious journals such as Journal of Biological Chemistry, Diabetes and Journal of the American Society of Nephrology.

In The Last Decade

Ryo Nagase

10 papers receiving 526 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryo Nagase Japan 8 205 193 142 106 86 10 530
Kosuke Yozai Japan 6 140 0.7× 143 0.7× 106 0.7× 71 0.7× 73 0.8× 6 387
Fabio Gianiorio Italy 9 211 1.0× 220 1.1× 95 0.7× 109 1.0× 94 1.1× 10 706
Yuichi Kido Japan 3 143 0.7× 124 0.6× 105 0.7× 75 0.7× 51 0.6× 4 350
Ji Eun Lee South Korea 11 109 0.5× 128 0.7× 68 0.5× 93 0.9× 95 1.1× 17 499
Yosuke Nagai Japan 12 205 1.0× 230 1.2× 80 0.6× 67 0.6× 194 2.3× 19 615
Ana Lúcia Mattar Brazil 9 210 1.0× 136 0.7× 65 0.5× 61 0.6× 81 0.9× 10 543
Giovanna Oddi Italy 8 131 0.6× 258 1.3× 114 0.8× 161 1.5× 60 0.7× 9 530
Hermann Joseph Gröne Germany 8 257 1.3× 323 1.7× 78 0.5× 58 0.5× 100 1.2× 8 863
Takashi Shimotomai Japan 10 208 1.0× 113 0.6× 74 0.5× 79 0.7× 105 1.2× 13 534
Cosimo Stambe Australia 7 301 1.5× 323 1.7× 53 0.4× 106 1.0× 46 0.5× 7 697

Countries citing papers authored by Ryo Nagase

Since Specialization
Citations

This map shows the geographic impact of Ryo Nagase's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryo Nagase with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryo Nagase more than expected).

Fields of papers citing papers by Ryo Nagase

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryo Nagase. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryo Nagase. The network helps show where Ryo Nagase may publish in the future.

Co-authorship network of co-authors of Ryo Nagase

This figure shows the co-authorship network connecting the top 25 collaborators of Ryo Nagase. A scholar is included among the top collaborators of Ryo Nagase based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryo Nagase. Ryo Nagase is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
1.
Kodera, Ryo, Kenichi Shikata, Akihiko Nakamura, et al.. (2017). The Glucose-lowering Efficacy of Sitagliptin in Obese Japanese Patients with Type 2 Diabetes. Internal Medicine. 56(6). 605–613. 10 indexed citations
2.
Nagase, Ryo, Nobuo Kajitani, Kenichi Shikata, et al.. (2012). Phenotypic change of macrophages in the progression of diabetic nephropathy; sialoadhesin-positive activated macrophages are increased in diabetic kidney. Clinical and Experimental Nephrology. 16(5). 739–748. 11 indexed citations
3.
Kido, Yuichi, Daisuke Ogawa, Kenichi Shikata, et al.. (2010). Intercellular adhesion molecule-1 plays a critical role in glomerulosclerosis after subtotal nephrectomy. Clinical and Experimental Nephrology. 15(2). 212–219. 2 indexed citations
4.
Nakatsuka, Atsuko, Jun Wada, Ryo Nagase, et al.. (2007). Hemophagocytic Syndrome Associated with Fatal Veno-Occlusive Disease in the Liver. Internal Medicine. 46(8). 495–500. 6 indexed citations
5.
Usui, Hitomi, Kenichi Shikata, Motofumi Sasaki, et al.. (2007). Macrophage Scavenger Receptor-A–Deficient Mice Are Resistant Against Diabetic Nephropathy Through Amelioration of Microinflammation. Diabetes. 56(2). 363–372. 77 indexed citations
6.
Tone, Atsuhito, Kenichi Shikata, Daisuke Ogawa, et al.. (2007). Changes of gene expression profiles in macrophages stimulated by angiotensin II — Angiotensin II induces MCP-2 through AT1-receptor. Journal of the Renin-Angiotensin-Aldosterone System. 8(1). 45–50. 22 indexed citations
7.
Yozai, Kosuke, Kenichi Shikata, Motofumi Sasaki, et al.. (2005). Methotrexate Prevents Renal Injury in Experimental Diabetic Rats via Anti-Inflammatory Actions. Journal of the American Society of Nephrology. 16(11). 3326–3338. 74 indexed citations
8.
Tone, Atsuhito, Kenichi Shikata, Motofumi Sasaki, et al.. (2005). Erythromycin ameliorates renal injury via anti-inflammatory effects in experimental diabetic rats. Diabetologia. 48(11). 2402–2411. 35 indexed citations
9.
Ogawa, Daisuke, Kenichi Shikata, Koichi Honke, et al.. (2004). Cerebroside Sulfotransferase Deficiency Ameliorates L-selectin-dependent Monocyte Infiltration in the Kidney after Ureteral Obstruction. Journal of Biological Chemistry. 279(3). 2085–2090. 33 indexed citations
10.
Okada, Shinichi, Kenichi Shikata, Mitsuhiro Matsuda, et al.. (2003). Intercellular Adhesion Molecule-1–Deficient Mice Are Resistant Against Renal Injury After Induction of Diabetes. Diabetes. 52(10). 2586–2593. 260 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026